GIND vs CURE
Comparison between Goldman Sachs India Equity ETF (GIND, ETF) and DIREXION DAILY HEALTHCARE BULL 3X SHARES (CURE, ETF).
GIND vs CURE - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Net Assets
Winner
GIND
$157M
CURE
$157M
Expense Ratio
GIND
0.75%
CURE
N/A
Max Drawdown
Winner
GIND
22.97%
CURE
69.19%
Sharpe Ratio
GIND
-1.06
Winner
CURE
0.72
5Y Beta
Winner
GIND
0.50
CURE
1.38
P/E Ratio
GIND
N/A
CURE
28.48
Forward P/E
GIND
N/A
CURE
18.22
5Y Dividends CAGR
GIND
N/A
CURE
63.21%
5Y EPS CAGR
GIND
N/A
CURE
12.57%
Debt to Equity
GIND
N/A
CURE
53.57%
P/S Ratio
GIND
N/A
CURE
1.55
P/B Ratio
GIND
N/A
CURE
4.81
GIND vs CURE - Holdings Comparison
GIND and CURE have 1 common holdings. Overlap is -3.15%
GIND's top 25 holdings weight is 50.47%. CURE's top 25 holdings weight is 91.92%.
| Rank | GIND | CURE |
|---|---|---|
| #1 | ICICI BANK LTD (n/a) - 5.44% | GOLDMAN FINL SQ TRSRY INST 506 (n/a) - 12.35% |
| #2 | HDFC BANK LTD (n/a) - 3.59% | ELI LILLY AND CO (LLY) - 11.75% |
| #3 | RELIANCE INDUSTRIES LTD (n/a) - 2.97% | DREYFUS GOVT CASH MAN INS (n/a) - 10.69% |
| #4 | INFOSYS LTD (n/a) - 2.59% | JOHNSON & JOHNSON (JNJ) - 7.72% |
| #5 | AXIS BANK LTD (n/a) - 2.53% | GOLDMAN SACHS FIN GOV 465 INSTITUT (n/a) - 7.02% |
| #6 | MAHINDRA & MAHINDRA LTD (n/a) - 2.42% | ABBVIE INC (ABBV) - 5.24% |
| #7 | BAJAJ FINANCE LTD (n/a) - 2.39% | UNITEDHEALTH GROUP INC (UNH) - 4.75% |
| #8 | TATA STEEL LTD (n/a) - 2.33% | MERCK & CO INC (MRK) - 4.14% |
| #9 | KOTAK MAHINDRA BANK LTD (n/a) - 2.25% | AMGEN INC (AMGN) - 2.52% |
| #10 | SUN PHARMACEUTICALS INDUSTRIES LTD (n/a) - 2.00% | THERMO FISHER SCIENTIFIC INC (TMO) - 2.34% |
| #11 | BHARTI AIRTEL LTD (n/a) - 1.91% | GILEAD SCIENCES INC (GILD) - 2.31% |
| #12 | GRASIM INDUSTRIES LTD (n/a) - 1.81% | INTUITIVE SURGICAL INC (ISRG) - 2.16% |
| #13 | STATE BANK OF INDIA (n/a) - 1.73% | ABBOTT LABORATORIES (ABT) - 2.10% |
| #14 | HINDALCO INDUSTRIES LTD (n/a) - 1.55% | PFIZER INC (PFE) - 2.05% |
| #15 | ETERNAL LTD (n/a) - 1.55% | BRISTOL-MYERS SQUIBB CO (BMY) - 1.65% |
| #16 | APOLLO HOSPITALS ENTERPRISE LTD (n/a) - 1.54% | CVS HEALTH CORP (CVS) - 1.61% |
| #17 | NESTLE INDIA LTD (n/a) - 1.49% | VERTEX PHARMACEUTICALS INC (VRTX) - 1.54% |
| #18 | SAMVARDHANA MOTHERSON INTERNATIONAL LTD (n/a) - 1.45% | DANAHER CORP (DHR) - 1.51% |
| #19 | TATA CONSUMER PRODUCTS LTD (n/a) - 1.42% | STRYKER CORP (SYK) - 1.50% |
| #20 | TVS MOTOR CO LTD (n/a) - 1.38% | MEDTRONIC PLC (MDT) - 1.38% |
| #21 | n/a (n/a) - 1.32% | MCKESSON CORP (MCK) - 1.29% |
| #22 | SBI LIFE INSURANCE CO LTD (n/a) - 1.27% | BOSTON SCIENTIFIC CORP (BSX) - 1.19% |
| #23 | BHARAT ELECTRONICS LTD (n/a) - 1.25% | ELEVANCE HEALTH INC (ELV) - 1.19% |
| #24 | TORRENT PHARMACEUTICALS LTD (n/a) - 1.16% | THE CIGNA GROUP (CI) - 1.03% |
| #25 | TD POWER SYSTEMS LTD (n/a) - 1.13% | REGENERON PHARMACEUTICALS INC (REGN) - 0.89% |
| Total Holdings | 123 | 65 |
GIND vs CURE - Historical Returns
Returns include dividend reinvestment.
1M
GIND
+2.92%
Winner
CURE
+15.36%
3M
Winner
GIND
+5.35%
CURE
+0.68%
6M
Winner
GIND
-7.68%
CURE
-11.16%
1Y
GIND
-10.66%
Winner
CURE
+27.18%
5Y(CAGR)
GIND
N/A
CURE
+1.04%
10Y(CAGR)
GIND
N/A
CURE
+13.46%
Max(CAGR)
GIND
-3.81%
Winner
CURE
+23.06%
GIND vs CURE - Annual Returns (2011 - 2026)
Returns include dividend reinvestment.
| Year | GIND | CURE |
|---|---|---|
| 2026 | -9.50% | -10.76% |
| 2025 | +4.55% | +22.87% |
| 2024 | N/A | -12.90% |
| 2023 | N/A | -8.46% |
| 2022 | N/A | -17.91% |
| 2021 | N/A | +90.55% |
| 2020 | N/A | +4.13% |
| 2019 | N/A | +62.36% |
| 2018 | N/A | -0.75% |
| 2017 | N/A | +62.77% |
| 2016 | N/A | -12.42% |
| 2015 | N/A | +6.24% |
| 2014 | N/A | +83.03% |
| 2013 | N/A | +153.15% |
| 2012 | N/A | +45.79% |
| 2011 | N/A | -9.68% |
GIND vs CURE Drawdown Comparison
The maximum drawdown for GIND was -22.97%, occurring on Mar 30, 2026. This drawdown has not yet recovered.
The maximum drawdown for CURE was -69.19%, occurring on Mar 23, 2020. Recovery took 242 trading sessions.
The current GIND drawdown is -13.45%. The current CURE drawdown is -28.29%.
| Rank | GIND | CURE |
|---|---|---|
| #1 | -22.97% Jul 1, 2025 - Mar 30, 2026 | -69.19% Jan 22, 2020 - Jan 6, 2021 |
| #2 | -5.81% Apr 3, 2025 - Apr 15, 2025 | -52.25% Apr 8, 2022 - Aug 7, 2025 |
| #3 | -4.08% May 5, 2025 - May 13, 2025 | -48.54% Jul 20, 2015 - Jun 22, 2017 |
| #4 | -2.80% Jun 10, 2025 - Jun 26, 2025 | -44.44% Jul 1, 2011 - Mar 15, 2012 |
| #5 | -1.87% Apr 24, 2025 - May 5, 2025 | -42.27% Oct 1, 2018 - Nov 27, 2019 |
| #6 | -1.60% May 19, 2025 - Jun 6, 2025 | -36.35% Jan 26, 2018 - Sep 13, 2018 |
| #7 | -0.79% Jun 27, 2025 - Jul 1, 2025 | -29.28% Dec 30, 2021 - Apr 8, 2022 |
| #8 | -0.29% Apr 22, 2025 - Apr 24, 2025 | -22.89% Aug 17, 2021 - Dec 15, 2021 |
| #9 | -0.06% Apr 15, 2025 - Apr 17, 2025 | -22.59% Sep 24, 2014 - Oct 28, 2014 |
| #10 | -0.04% May 15, 2025 - May 19, 2025 | -19.78% Mar 4, 2014 - Jun 19, 2014 |
| #11 | N/A | -19.31% Oct 17, 2012 - Jan 9, 2013 |
| #12 | N/A | -19.31% Jan 20, 2021 - Apr 15, 2021 |
| #13 | N/A | -17.38% Apr 2, 2012 - Jun 29, 2012 |
| #14 | N/A | -15.49% May 28, 2013 - Jul 12, 2013 |
| #15 | N/A | -14.96% Dec 8, 2014 - Jan 22, 2015 |
Correlation
Correlation between GIND and CURE is -0.21 which considered as a very weak or no correlation - the stocks move independently of each other.
-0.21
-101
Select Stocks to Compare
Popular: GIND vs SPYCURE vs SPY
More Comparisons
Compare with similar stocks